|
| Press Releases |
|
 |
|
| Monday, May 16, 2016 |
|
|
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology |
| Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons. more info >> |
|
| Friday, May 13, 2016 |
|
|
New Technique Paves the Way for Drug Targeting to Fight Microbial Resistance |
| Research investigators in Singapore have developed a new high throughput method that identifies how ribonucleic acid (RNA) molecules come together in an unbiased and large-scale manner inside cells. more info >> |
|
| Wednesday, May 11, 2016 |
|
|
Scientists Discover New Technology Breakthrough in Fighting Viral Diseases |
| Today, IBM Research (NYSE: IBM) and Singapore's Institute of Bioengineering and Nanotechnology (IBN) announced that they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance. more info >> |
|
| Wednesday, February 3, 2016 |
|
|
A*STAR and US EPA to Co-develop Innovative Methods to Assess and Predict the Safety of Chemicals, without Relying on Animal Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and the United States Environmental Protection Agency (EPA) are partnering to develop new approaches to identify chemicals that could pose a risk to human health. more info >> |
|
| Monday, January 25, 2016 |
|
|
International Collaboration to Advance Research on Non-Animal Approaches to Chemical Safety Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and the United States Environmental Protection Agency (EPA) are partnering to develop new approaches to identify chemicals that could pose a risk to human health. more info >> |
|
| Friday, November 6, 2015 |
|
|
Scratching the Surface of Skin Disease |
| An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes. more info >> |
|
| Wednesday, November 4, 2015 |
|
|
Two A*STAR Scientists Clinch Prestigious 2015 EMBO Young Investigator Awards |
| Two A*STAR scientists have joined 21 other scientists as EMBO Young Investigators, becoming part of an international network that represents some of the best young researchers in Europe and beyond. more info >> |
|
| Thursday, October 29, 2015 |
|
|
A*STAR Findings on Breast Cancer Hold Potential for New Treatments |
| Scientists at the Bioinformatics Institute (BII) and Genome Institute of Singapore (GIS), research institutes under the Agency for Science, Technology and Research (A*STAR), have made discoveries that could lead to new ways of diagnosing and treating breast cancer. more info >> |
|
| Monday, September 21, 2015 |
|
|
A*STAR Scientists Reveal How Stem Cells Defend Against Viruses |
| Scientists from the Institute of Molecular and Cell Biology, a research institute under the Agency for Science, Technology and Research, Singapore, have uncovered the mechanisms which embryonic stem cells employ to inhibit virus expression. The ground-breaking discovery could potentially advance stem cell therapeutics and diagnostics. more info >> |
|
| Thursday, July 16, 2015 |
|
|
First Made-in-Singapore Cancer Drug Enters Clinical Testing |
| A made-in-Singapore cancer drug has advanced into clinical trials, charting a milestone in Singapore's biomedical sciences initiative that will go towards improving the lives of cancer patients in Singapore, and worldwide. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Launches Short-Drama Marketing Ecosystem Launch in the Dominican Republic, Paving the Way for Digital Content Innovation
Mar 14, 2026 05:00 HKT/SGT
|
|
|
General MRO Aerospace 取得中國民航局認證，拓展全球維修能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace 获得中国民航局认证，拓展全球维护能力
Mar 13, 2026 22:20 HKT/SGT
|
|
|
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities
Mar 13, 2026 22:20 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00: JST
|
|
|
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China
Mar 13, 2026 22:00 HKT/SGT
|
|
|
CITIC Resources Deepens Dual-Engine Strategy of 'Investment + Trading', Continues to Promote High-Quality Development
Mar 13, 2026 21:01 HKT/SGT
|
|
|
中信資源深化「投資+貿易」雙輪戰略 持續驅動高質量發展 推進「上游資產布局、貿易業務拓展、生產運營提質」
Mar 13, 2026 20:53 HKT/SGT
|
|
|
中信资源深化「投资+贸易」双轮战略 持续驱动高质量发展 推进「上游资产布局、贸易业务拓展、生产运营提质」
Mar 13, 2026 20:40 HKT/SGT
|
|
|
康哲藥業：腎性貧血新藥德昔度司他片中國獲批上市
Mar 13, 2026 20:24 HKT/SGT
|
|
|
康哲药业：肾性贫血新药德昔度司他片中国获批上市
Mar 13, 2026 20:15 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 18:00: JST
|
|
|
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating "Online x Offline" O2O Community Finance Strategy
Mar 13, 2026 17:34 HKT/SGT
|
|
|
盈立證券一年拓展12個服務網點 全力深化「線上x線下」O2O社區金融佈局
Mar 13, 2026 17:21 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo
Mar 13, 2026 17:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
